---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-027927"
form_type: "8-K"
ticker: "AHCO"
cik: "0001725255"
company_name: "AdaptHealth Corp."
filed_at: "2023-08-08T23:59:59+00:00"
generated_at: "2026-06-12T02:21:25.478056+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# AdaptHealth Q2 net revenue $793M (+9% YoY), net income flat $14M; Adj. EBITDA $171M (+14%); FY guidance narrowed

## Summary
- Net revenue $793.3M, +9.0% YoY; non-acquired net revenue growth 8.7%.
- Net income attributable $14.0M (flat YoY); Adjusted EBITDA $171.0M (+14.0%).
- Year-to-date cash flow from ops $226.6M (up from $169.9M); free cash flow $54.8M (up from $15.6M).
- FY2023 guidance narrowed: net revenue $3.16-3.20B (prior $3.16-3.24B); Adj. EBITDA $650-680M (prior $650-710M).
- Planned CEO transition: Crispin Teufel to join as CEO in September 2023.

## SEC filing metadata
- accession: 0001628280-23-027927
- form_type: 8-K
- ticker: AHCO
- cik: 0001725255
- company_name: AdaptHealth Corp.
- filed_at: 2023-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725255/000162828023027927/0001628280-23-027927-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725255/000162828023027927/ahco-20230808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-027927
- JSON: https://secwatch.observer/filing/0001628280-23-027927.json
- Plain text: https://secwatch.observer/filing/0001628280-23-027927.txt

## Key facts
- Earnings Releases
  AdaptHealth Corp. reported the second quarter ended June 30, 2023 results: revenue $793.3 million, net income $14.0 million. Guidance lowered.
  - Period: the second quarter ended June 30, 2023
  - Revenue: $793.3 million
  - Net income: $14.0 million
  - Guidance: lowered
  - Result: reported results
  source text: AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”) , a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quarter ended June 30, 2023. Second Quarter Results and Highlights All comparisons are to the quarter ended June 30, 2022 unless otherwise stated. • Net revenue was $793.3 million compared to $727.6 million, an increase of 9.0% . ◦ Non-acquired net revenue growth was 8.7%. • Net income attributable to AdaptHealth Corp. was $14.0 million, compared to $14.0 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725255/000162828023027927/0001628280-23-027927-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.